semaglutide group Rybelsus® Compounded Semaglutide (GLP-1)

Hershey, the confectionery titan, acknowledged a mild year-on-year impact in November 2024, carefully worded language masking deeper structural concern

If sleep apnoea is suspected, your GP may refer you to sleep services in line with NICE guidance (NG202)

This is the same year the FDA approved use of the GLP-1 drug semaglutide, or Wegovy, for weight loss in 12- to 17-year-olds with obesity

The early clinical adoption suggests that some practitioners believe the potential benefits outweigh the risks

Wegovy works by mimicking the GLP-1 hormone, which signals the brain to reduce hunger and increase feelings of fullness

Revue mdicale suisse Mdecine et Hygine Chemin de la Mousse 46 1225 Chne-Bourg Suisse Comit de rdaction Dr B